1. Home
  2. OGN vs BRZE Comparison

OGN vs BRZE Comparison

Compare OGN & BRZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • BRZE
  • Stock Information
  • Founded
  • OGN 1923
  • BRZE 2011
  • Country
  • OGN United States
  • BRZE United States
  • Employees
  • OGN N/A
  • BRZE N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • BRZE Computer Software: Prepackaged Software
  • Sector
  • OGN Health Care
  • BRZE Technology
  • Exchange
  • OGN Nasdaq
  • BRZE Nasdaq
  • Market Cap
  • OGN 3.9B
  • BRZE 3.6B
  • IPO Year
  • OGN N/A
  • BRZE 2021
  • Fundamental
  • Price
  • OGN $14.50
  • BRZE $44.31
  • Analyst Decision
  • OGN Hold
  • BRZE Strong Buy
  • Analyst Count
  • OGN 3
  • BRZE 20
  • Target Price
  • OGN $21.33
  • BRZE $54.30
  • AVG Volume (30 Days)
  • OGN 4.5M
  • BRZE 1.9M
  • Earning Date
  • OGN 02-13-2025
  • BRZE 12-09-2024
  • Dividend Yield
  • OGN 7.68%
  • BRZE N/A
  • EPS Growth
  • OGN 120.97
  • BRZE N/A
  • EPS
  • OGN 5.04
  • BRZE N/A
  • Revenue
  • OGN $6,409,000,000.00
  • BRZE $563,967,000.00
  • Revenue This Year
  • OGN $3.11
  • BRZE $27.28
  • Revenue Next Year
  • OGN $2.55
  • BRZE $16.96
  • P/E Ratio
  • OGN $2.89
  • BRZE N/A
  • Revenue Growth
  • OGN 4.21
  • BRZE 28.31
  • 52 Week Low
  • OGN $13.58
  • BRZE $29.18
  • 52 Week High
  • OGN $23.10
  • BRZE $61.53
  • Technical
  • Relative Strength Index (RSI)
  • OGN 37.20
  • BRZE 68.44
  • Support Level
  • OGN $14.39
  • BRZE $42.67
  • Resistance Level
  • OGN $15.15
  • BRZE $45.78
  • Average True Range (ATR)
  • OGN 0.52
  • BRZE 2.26
  • MACD
  • OGN -0.02
  • BRZE 0.07
  • Stochastic Oscillator
  • OGN 8.63
  • BRZE 74.35

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates a majority of its revenue from the United States.

Share on Social Networks: